BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nijampatnam B, Liotta DC. Recent advances in the development of HBV capsid assembly modulators. Current Opinion in Chemical Biology 2019;50:73-9. [DOI: 10.1016/j.cbpa.2019.02.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 van den Berg F, Limani SW, Mnyandu N, Maepa MB, Ely A, Arbuthnot P. Advances with RNAi-Based Therapy for Hepatitis B Virus Infection. Viruses 2020;12:E851. [PMID: 32759756 DOI: 10.3390/v12080851] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
2 Wang Y, Wang Z, Liu J, Wang Y, Wu R, Sheng R, Hou T. Discovery of novel HBV capsid assembly modulators by structure-based virtual screening and bioassays. Bioorg Med Chem 2021;36:116096. [PMID: 33721800 DOI: 10.1016/j.bmc.2021.116096] [Reference Citation Analysis]
3 Sabnis RW. Combination Therapy of RNA Interference and Small Molecules for Treating Hepatitis B Virus Infection. ACS Med Chem Lett 2021;12:858-9. [PMID: 34141056 DOI: 10.1021/acsmedchemlett.1c00103] [Reference Citation Analysis]
4 Lv K, Wu S, Tao Z, Wang A, Xu S, Yang L, Gao Q, Wang A, Qin X, Jiang B, Wu W, Jia X, Li Y, Jiang J, Liu M. Identification of (6S)-cyclopropyl-6,7-dihydropyrazolo[1,5-a]pyrazine-5(4H)-carboxamines as new HBV capsid assembly modulators. Eur J Med Chem 2021;:113974. [PMID: 34772528 DOI: 10.1016/j.ejmech.2021.113974] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kim H, Ko C, Lee JY, Kim M. Current Progress in the Development of Hepatitis B Virus Capsid Assembly Modulators: Chemical Structure, Mode-of-Action and Efficacy. Molecules 2021;26:7420. [PMID: 34946502 DOI: 10.3390/molecules26247420] [Reference Citation Analysis]
6 Viswanathan U, Mani N, Hu Z, Ban H, Du Y, Hu J, Chang J, Guo JT. Targeting the multifunctional HBV core protein as a potential cure for chronic hepatitis B. Antiviral Res 2020;182:104917. [PMID: 32818519 DOI: 10.1016/j.antiviral.2020.104917] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
7 Amblard F, Boucle S, Bassit L, Chen Z, Sari O, Cox B, Verma K, Ozturk T, Ollinger-Russell O, Schinazi RF. Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents. Bioorg Med Chem 2021;31:115952. [PMID: 33421915 DOI: 10.1016/j.bmc.2020.115952] [Reference Citation Analysis]
8 Luo Y, Cheng J, Hu Z, Ban H, Wu S, Hwang N, Kulp J, Li Y, Du Y, Chang J, Viswanathan U, Guo JT. Identification of hepatitis B virus core protein residues critical for capsid assembly, pgRNA encapsidation and resistance to capsid assembly modulators. Antiviral Res 2021;191:105080. [PMID: 33933516 DOI: 10.1016/j.antiviral.2021.105080] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Chen W, Liu F, Zhao Q, Ma X, Lu D, Li H, Zeng Y, Tong X, Zeng L, Liu J, Yang L, Zuo J, Hu Y. Discovery of Phthalazinone Derivatives as Novel Hepatitis B Virus Capsid Inhibitors. J Med Chem. 2020;63:8134-8145. [PMID: 32692159 DOI: 10.1021/acs.jmedchem.0c00346] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Tu T, Zehnder B, Qu B, Urban S. D e novo synthesis of hepatitis B virus nucleocapsids is dispensable for the maintenance and transcriptional regulation of cccDNA. JHEP Rep. 2021;3:100195. [PMID: 33385130 DOI: 10.1016/j.jhepr.2020.100195] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
11 Liu Y, Chang S, Hsieh D, Burdette D, Martin R, Mo H, Feierbach B. Generation of an HBV core phenotyping assay for evaluating HBV capsid compounds. J Virol Methods 2021;292:114117. [PMID: 33657432 DOI: 10.1016/j.jviromet.2021.114117] [Reference Citation Analysis]
12 Wei F, Kang D, Cherukupalli S, Zalloum WA, Zhang T, Liu X, Zhan P. Discovery and optimizing polycyclic pyridone compounds as anti-HBV agents. Expert Opin Ther Pat 2020;30:715-21. [PMID: 32746660 DOI: 10.1080/13543776.2020.1801641] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Hwang N, Ban H, Wu S, McGuire K, Hernandez E, Chen J, Zhao Q, Suresh M, Blass B, Viswanathan U, Kulp J, Chang J, Clement J, Menne S, Guo JT, Du Y. 4-Oxooctahydroquinoline-1(2H)-carboxamides as hepatitis B virus (HBV) capsid core protein assembly modulators. Bioorg Med Chem Lett 2021;58:128518. [PMID: 34979256 DOI: 10.1016/j.bmcl.2021.128518] [Reference Citation Analysis]
14 Hozáková L, Vokatá B, Ruml T, Ulbrich P. Targeting the Virus Capsid as a Tool to Fight RNA Viruses. Viruses 2022;14:174. [DOI: 10.3390/v14020174] [Reference Citation Analysis]
15 Ely A, Singh P, Smith TS, Arbuthnot P. In vitro transcribed mRNA for expression of designer nucleases: Advantages as a novel therapeutic for the management of chronic HBV infection. Adv Drug Deliv Rev 2021;168:134-46. [PMID: 32485207 DOI: 10.1016/j.addr.2020.05.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
16 Lv K, Wu S, Li W, Geng Y, Wu M, Zhou J, Li Y, Gao Q, Liu M. Design, synthesis and anti-HBV activity of NVR3-778 derivatives. Bioorganic Chemistry 2020;94:103363. [DOI: 10.1016/j.bioorg.2019.103363] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
17 Wang S, Fogeron ML, Schledorn M, Dujardin M, Penzel S, Burdette D, Berke JM, Nassal M, Lecoq L, Meier BH, Böckmann A. Combining Cell-Free Protein Synthesis and NMR Into a Tool to Study Capsid Assembly Modulation. Front Mol Biosci 2019;6:67. [PMID: 31440516 DOI: 10.3389/fmolb.2019.00067] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
18 Niklasch M, Zimmermann P, Nassal M. The Hepatitis B Virus Nucleocapsid-Dynamic Compartment for Infectious Virus Production and New Antiviral Target. Biomedicines 2021;9:1577. [PMID: 34829806 DOI: 10.3390/biomedicines9111577] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Lee YH, Cha HM, Hwang JY, Park SY, Vishakantegowda AG, Imran A, Lee JY, Yi YS, Jun S, Kim GH, Kang HJ, Chung SJ, Kim M, Kim H, Han SB. Sulfamoylbenzamide-based Capsid Assembly Modulators for Selective Inhibition of Hepatitis B Viral Replication. ACS Med Chem Lett 2021;12:242-8. [PMID: 33603970 DOI: 10.1021/acsmedchemlett.0c00606] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
20 Thangamani L, Balasubramanian B, Easwaran M, Natarajan J, Pushparaj K, Meyyazhagan A, Piramanayagam S. GalNAc-siRNA conjugates: Prospective tools on the frontier of anti-viral therapeutics. Pharmacol Res 2021;173:105864. [PMID: 34474100 DOI: 10.1016/j.phrs.2021.105864] [Reference Citation Analysis]
21 Hwang N, Ban H, Chen J, Ma J, Liu H, Lam P, Kulp J, Menne S, Chang J, Guo JT, Du Y. Synthesis of 4-oxotetrahydropyrimidine-1(2H)-carboxamides derivatives as capsid assembly modulators of hepatitis B virus. Med Chem Res 2021;:1-14. [PMID: 33456291 DOI: 10.1007/s00044-020-02677-3] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
22 Kostyushev D, Kostyusheva A, Ponomareva N, Brezgin S, Chulanov V. CRISPR/Cas and Hepatitis B Therapy: Technological Advances and Practical Barriers. Nucleic Acid Ther 2021. [PMID: 34797701 DOI: 10.1089/nat.2021.0075] [Reference Citation Analysis]
23 Maepa MB, Bloom K, Ely A, Arbuthnot P. Hepatitis B virus: promising drug targets and therapeutic implications. Expert Opin Ther Targets 2021;25:451-66. [PMID: 33843412 DOI: 10.1080/14728222.2021.1915990] [Reference Citation Analysis]
24 Senaweera S, Du H, Zhang H, Kirby KA, Tedbury PR, Xie J, Sarafianos SG, Wang Z. Discovery of New Small Molecule Hits as Hepatitis B Virus Capsid Assembly Modulators: Structure and Pharmacophore-Based Approaches. Viruses 2021;13:770. [PMID: 33925540 DOI: 10.3390/v13050770] [Reference Citation Analysis]
25 Pavlova A, Bassit L, Cox BD, Korablyov M, Chipot C, Patel D, Lynch DL, Amblard F, Schinazi RF, Gumbart JC. The Mechanism of Action of Hepatitis B Virus Capsid Assembly Modulators Can Be Predicted from Binding to Early Assembly Intermediates. J Med Chem 2022. [PMID: 35290049 DOI: 10.1021/acs.jmedchem.1c02040] [Reference Citation Analysis]